#Contraceptives

A newly released international report assessing the landscape of contraceptive supplies provides crucial insights for family planning stakeholders worldwide, with implications for policy and practice in Thailand. The 2024 Family Planning Market Report, jointly published by the Clinton Health Access Initiative and the Reproductive Health Supplies Coalition, delivers an extensive analysis of the evolving global market for reproductive health commodities, highlighting both progress and ongoing challenges in ensuring access to contraceptives for millions of women and couples.

A recent study is making international headlines by finding a significant association between hormonal contraceptive use and a heightened risk of developing depression, raising important questions for millions of Thai women who rely on these family planning methods. The research, covered by reputable sources such as Drug Topics, suggests that women using hormonal contraceptives—such as birth control pills, patches, injections, and implants—may be more likely to experience depression, especially soon after starting these medications.